nodes	percent_of_prediction	percent_of_DWPC	metapath
Temazepam—CYP2C19—Teniposide—lymphatic system cancer	0.0958	0.296	CbGbCtD
Temazepam—CYP2C9—Teniposide—lymphatic system cancer	0.0796	0.246	CbGbCtD
Temazepam—CYP3A4—Cytarabine—lymphatic system cancer	0.047	0.145	CbGbCtD
Temazepam—CYP3A4—Teniposide—lymphatic system cancer	0.0463	0.143	CbGbCtD
Temazepam—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0324	0.1	CbGbCtD
Temazepam—CYP3A4—Vincristine—lymphatic system cancer	0.0223	0.0689	CbGbCtD
Temazepam—Obstructive airways disorder—Methotrexate—lymphatic system cancer	0.0143	0.0212	CcSEcCtD
Temazepam—Proteinuria—Fludarabine—lymphatic system cancer	0.0125	0.0185	CcSEcCtD
Temazepam—Protein urine present—Fludarabine—lymphatic system cancer	0.0123	0.0182	CcSEcCtD
Temazepam—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.0115	0.017	CcSEcCtD
Temazepam—Coma—Fludarabine—lymphatic system cancer	0.01	0.0148	CcSEcCtD
Temazepam—Depression—Mechlorethamine—lymphatic system cancer	0.00944	0.014	CcSEcCtD
Temazepam—Nystagmus—Vincristine—lymphatic system cancer	0.00938	0.0139	CcSEcCtD
Temazepam—Jaundice—Mechlorethamine—lymphatic system cancer	0.00923	0.0136	CcSEcCtD
Temazepam—Sleep disorder—Fludarabine—lymphatic system cancer	0.0092	0.0136	CcSEcCtD
Temazepam—Aggression—Bleomycin—lymphatic system cancer	0.00915	0.0135	CcSEcCtD
Temazepam—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00884	0.0131	CcSEcCtD
Temazepam—Visual disturbance—Fludarabine—lymphatic system cancer	0.0084	0.0124	CcSEcCtD
Temazepam—Alopecia—Mechlorethamine—lymphatic system cancer	0.00751	0.0111	CcSEcCtD
Temazepam—Leukocytosis—Carmustine—lymphatic system cancer	0.00747	0.011	CcSEcCtD
Temazepam—Proteinuria—Mitoxantrone—lymphatic system cancer	0.00743	0.011	CcSEcCtD
Temazepam—Protein urine present—Mitoxantrone—lymphatic system cancer	0.00733	0.0108	CcSEcCtD
Temazepam—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00678	0.01	CcSEcCtD
Temazepam—Vertigo—Mechlorethamine—lymphatic system cancer	0.00665	0.00983	CcSEcCtD
Temazepam—Disorientation—Bleomycin—lymphatic system cancer	0.00653	0.00965	CcSEcCtD
Temazepam—Coma—Carmustine—lymphatic system cancer	0.00642	0.00948	CcSEcCtD
Temazepam—Coma—Vincristine—lymphatic system cancer	0.00612	0.00905	CcSEcCtD
Temazepam—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00591	0.00874	CcSEcCtD
Temazepam—Anorexia—Mechlorethamine—lymphatic system cancer	0.00576	0.00851	CcSEcCtD
Temazepam—Alopecia—Teniposide—lymphatic system cancer	0.00554	0.00819	CcSEcCtD
Temazepam—Amnesia—Carmustine—lymphatic system cancer	0.00542	0.00802	CcSEcCtD
Temazepam—Visual impairment—Fludarabine—lymphatic system cancer	0.00531	0.00785	CcSEcCtD
Temazepam—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00525	0.00776	CcSEcCtD
Temazepam—Hyponatraemia—Carmustine—lymphatic system cancer	0.00512	0.00756	CcSEcCtD
Temazepam—Diplopia—Carmustine—lymphatic system cancer	0.0051	0.00753	CcSEcCtD
Temazepam—Agitation—Teniposide—lymphatic system cancer	0.00501	0.00741	CcSEcCtD
Temazepam—Hyponatraemia—Vincristine—lymphatic system cancer	0.00488	0.00722	CcSEcCtD
Temazepam—Alopecia—Fludarabine—lymphatic system cancer	0.00487	0.00719	CcSEcCtD
Temazepam—Ataxia—Carmustine—lymphatic system cancer	0.00479	0.00708	CcSEcCtD
Temazepam—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00476	0.00703	CcSEcCtD
Temazepam—Ataxia—Vincristine—lymphatic system cancer	0.00457	0.00676	CcSEcCtD
Temazepam—Confusional state—Teniposide—lymphatic system cancer	0.00449	0.00664	CcSEcCtD
Temazepam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00445	0.00658	CcSEcCtD
Temazepam—Agitation—Fludarabine—lymphatic system cancer	0.00441	0.00651	CcSEcCtD
Temazepam—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00436	0.00644	CcSEcCtD
Temazepam—Tachycardia—Teniposide—lymphatic system cancer	0.00435	0.00642	CcSEcCtD
Temazepam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00431	0.00636	CcSEcCtD
Temazepam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00427	0.00632	CcSEcCtD
Temazepam—Anorexia—Teniposide—lymphatic system cancer	0.00424	0.00627	CcSEcCtD
Temazepam—Hypotension—Teniposide—lymphatic system cancer	0.00416	0.00615	CcSEcCtD
Temazepam—Convulsion—Fludarabine—lymphatic system cancer	0.00416	0.00614	CcSEcCtD
Temazepam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00413	0.00611	CcSEcCtD
Temazepam—Dyspnoea—Teniposide—lymphatic system cancer	0.00397	0.00587	CcSEcCtD
Temazepam—Confusional state—Fludarabine—lymphatic system cancer	0.00395	0.00583	CcSEcCtD
Temazepam—Depression—Carmustine—lymphatic system cancer	0.00392	0.00579	CcSEcCtD
Temazepam—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00387	0.00572	CcSEcCtD
Temazepam—Decreased appetite—Teniposide—lymphatic system cancer	0.00387	0.00572	CcSEcCtD
Temazepam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00384	0.00568	CcSEcCtD
Temazepam—Apnoea—Methotrexate—lymphatic system cancer	0.00384	0.00567	CcSEcCtD
Temazepam—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00383	0.00566	CcSEcCtD
Temazepam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00378	0.00559	CcSEcCtD
Temazepam—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00377	0.00557	CcSEcCtD
Temazepam—Depression—Vincristine—lymphatic system cancer	0.00374	0.00553	CcSEcCtD
Temazepam—Anorexia—Fludarabine—lymphatic system cancer	0.00373	0.00551	CcSEcCtD
Temazepam—Proteinuria—Methotrexate—lymphatic system cancer	0.0037	0.00547	CcSEcCtD
Temazepam—Feeling abnormal—Teniposide—lymphatic system cancer	0.00367	0.00542	CcSEcCtD
Temazepam—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00365	0.0054	CcSEcCtD
Temazepam—Protein urine present—Methotrexate—lymphatic system cancer	0.00365	0.00539	CcSEcCtD
Temazepam—Nausea—Mechlorethamine—lymphatic system cancer	0.00359	0.0053	CcSEcCtD
Temazepam—Alopecia—Bleomycin—lymphatic system cancer	0.00357	0.00528	CcSEcCtD
Temazepam—Jaundice—Mitoxantrone—lymphatic system cancer	0.00356	0.00526	CcSEcCtD
Temazepam—Hallucination—Carmustine—lymphatic system cancer	0.00351	0.00518	CcSEcCtD
Temazepam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00349	0.00516	CcSEcCtD
Temazepam—Dysarthria—Methotrexate—lymphatic system cancer	0.00344	0.00508	CcSEcCtD
Temazepam—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00341	0.00504	CcSEcCtD
Temazepam—Decreased appetite—Fludarabine—lymphatic system cancer	0.0034	0.00503	CcSEcCtD
Temazepam—Visual impairment—Carmustine—lymphatic system cancer	0.0034	0.00502	CcSEcCtD
Temazepam—Fatigue—Fludarabine—lymphatic system cancer	0.00337	0.00499	CcSEcCtD
Temazepam—Hallucination—Vincristine—lymphatic system cancer	0.00335	0.00495	CcSEcCtD
Temazepam—Constipation—Fludarabine—lymphatic system cancer	0.00335	0.00495	CcSEcCtD
Temazepam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00328	0.00485	CcSEcCtD
Temazepam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00323	0.00477	CcSEcCtD
Temazepam—Asthenia—Teniposide—lymphatic system cancer	0.0032	0.00472	CcSEcCtD
Temazepam—Pruritus—Teniposide—lymphatic system cancer	0.00315	0.00466	CcSEcCtD
Temazepam—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00314	0.00464	CcSEcCtD
Temazepam—Alopecia—Carmustine—lymphatic system cancer	0.00312	0.0046	CcSEcCtD
Temazepam—Diarrhoea—Teniposide—lymphatic system cancer	0.00305	0.0045	CcSEcCtD
Temazepam—Alopecia—Vincristine—lymphatic system cancer	0.00297	0.0044	CcSEcCtD
Temazepam—Coma—Methotrexate—lymphatic system cancer	0.00297	0.00439	CcSEcCtD
Temazepam—Back pain—Carmustine—lymphatic system cancer	0.00297	0.00439	CcSEcCtD
Temazepam—Alopecia—Mitoxantrone—lymphatic system cancer	0.0029	0.00428	CcSEcCtD
Temazepam—Confusional state—Bleomycin—lymphatic system cancer	0.00289	0.00428	CcSEcCtD
Temazepam—Vision blurred—Carmustine—lymphatic system cancer	0.00289	0.00427	CcSEcCtD
Temazepam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00288	0.00426	CcSEcCtD
Temazepam—Tremor—Carmustine—lymphatic system cancer	0.00288	0.00425	CcSEcCtD
Temazepam—Back pain—Vincristine—lymphatic system cancer	0.00283	0.00419	CcSEcCtD
Temazepam—Vomiting—Teniposide—lymphatic system cancer	0.00283	0.00418	CcSEcCtD
Temazepam—Agitation—Carmustine—lymphatic system cancer	0.00282	0.00417	CcSEcCtD
Temazepam—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00281	0.00415	CcSEcCtD
Temazepam—Asthenia—Fludarabine—lymphatic system cancer	0.00281	0.00415	CcSEcCtD
Temazepam—Headache—Teniposide—lymphatic system cancer	0.00279	0.00412	CcSEcCtD
Temazepam—Pruritus—Fludarabine—lymphatic system cancer	0.00277	0.00409	CcSEcCtD
Temazepam—Back pain—Mitoxantrone—lymphatic system cancer	0.00276	0.00408	CcSEcCtD
Temazepam—Anorexia—Bleomycin—lymphatic system cancer	0.00274	0.00404	CcSEcCtD
Temazepam—Agitation—Vincristine—lymphatic system cancer	0.00269	0.00398	CcSEcCtD
Temazepam—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00269	0.00397	CcSEcCtD
Temazepam—Hypotension—Bleomycin—lymphatic system cancer	0.00268	0.00396	CcSEcCtD
Temazepam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00268	0.00396	CcSEcCtD
Temazepam—Convulsion—Carmustine—lymphatic system cancer	0.00266	0.00393	CcSEcCtD
Temazepam—Nausea—Teniposide—lymphatic system cancer	0.00265	0.00391	CcSEcCtD
Temazepam—Vertigo—Vincristine—lymphatic system cancer	0.00263	0.00389	CcSEcCtD
Temazepam—Anxiety—Carmustine—lymphatic system cancer	0.0026	0.00385	CcSEcCtD
Temazepam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00256	0.00378	CcSEcCtD
Temazepam—Convulsion—Vincristine—lymphatic system cancer	0.00254	0.00375	CcSEcCtD
Temazepam—Confusional state—Carmustine—lymphatic system cancer	0.00253	0.00373	CcSEcCtD
Temazepam—Decreased appetite—Bleomycin—lymphatic system cancer	0.00249	0.00369	CcSEcCtD
Temazepam—Visual disturbance—Methotrexate—lymphatic system cancer	0.00249	0.00368	CcSEcCtD
Temazepam—Vomiting—Fludarabine—lymphatic system cancer	0.00249	0.00368	CcSEcCtD
Temazepam—Convulsion—Mitoxantrone—lymphatic system cancer	0.00247	0.00365	CcSEcCtD
Temazepam—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00245	0.00362	CcSEcCtD
Temazepam—Headache—Fludarabine—lymphatic system cancer	0.00245	0.00362	CcSEcCtD
Temazepam—Tachycardia—Carmustine—lymphatic system cancer	0.00244	0.00361	CcSEcCtD
Temazepam—Anxiety—Mitoxantrone—lymphatic system cancer	0.00242	0.00358	CcSEcCtD
Temazepam—Lethargy—Methotrexate—lymphatic system cancer	0.00241	0.00356	CcSEcCtD
Temazepam—Anorexia—Carmustine—lymphatic system cancer	0.00239	0.00353	CcSEcCtD
Temazepam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00236	0.00349	CcSEcCtD
Temazepam—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00236	0.00349	CcSEcCtD
Temazepam—Confusional state—Mitoxantrone—lymphatic system cancer	0.00235	0.00347	CcSEcCtD
Temazepam—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00234	0.00346	CcSEcCtD
Temazepam—Hypotension—Carmustine—lymphatic system cancer	0.00234	0.00346	CcSEcCtD
Temazepam—Nausea—Fludarabine—lymphatic system cancer	0.00232	0.00344	CcSEcCtD
Temazepam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00231	0.00342	CcSEcCtD
Temazepam—Shock—Mitoxantrone—lymphatic system cancer	0.00229	0.00339	CcSEcCtD
Temazepam—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00228	0.00337	CcSEcCtD
Temazepam—Anorexia—Vincristine—lymphatic system cancer	0.00228	0.00337	CcSEcCtD
Temazepam—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00227	0.00336	CcSEcCtD
Temazepam—Irritability—Methotrexate—lymphatic system cancer	0.00225	0.00333	CcSEcCtD
Temazepam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00225	0.00333	CcSEcCtD
Temazepam—Hypotension—Vincristine—lymphatic system cancer	0.00223	0.0033	CcSEcCtD
Temazepam—Dyspnoea—Carmustine—lymphatic system cancer	0.00223	0.0033	CcSEcCtD
Temazepam—Somnolence—Carmustine—lymphatic system cancer	0.00223	0.00329	CcSEcCtD
Temazepam—Anorexia—Mitoxantrone—lymphatic system cancer	0.00222	0.00328	CcSEcCtD
Temazepam—Ataxia—Methotrexate—lymphatic system cancer	0.00222	0.00328	CcSEcCtD
Temazepam—Decreased appetite—Carmustine—lymphatic system cancer	0.00218	0.00322	CcSEcCtD
Temazepam—Hypotension—Mitoxantrone—lymphatic system cancer	0.00218	0.00322	CcSEcCtD
Temazepam—Constipation—Carmustine—lymphatic system cancer	0.00214	0.00317	CcSEcCtD
Temazepam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00211	0.00312	CcSEcCtD
Temazepam—Decreased appetite—Vincristine—lymphatic system cancer	0.00208	0.00307	CcSEcCtD
Temazepam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00208	0.00307	CcSEcCtD
Temazepam—Somnolence—Mitoxantrone—lymphatic system cancer	0.00207	0.00306	CcSEcCtD
Temazepam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00206	0.00305	CcSEcCtD
Temazepam—Fatigue—Vincristine—lymphatic system cancer	0.00206	0.00305	CcSEcCtD
Temazepam—Asthenia—Bleomycin—lymphatic system cancer	0.00206	0.00304	CcSEcCtD
Temazepam—Constipation—Vincristine—lymphatic system cancer	0.00204	0.00302	CcSEcCtD
Temazepam—Pruritus—Bleomycin—lymphatic system cancer	0.00203	0.003	CcSEcCtD
Temazepam—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00202	0.00299	CcSEcCtD
Temazepam—Fatigue—Mitoxantrone—lymphatic system cancer	0.00201	0.00297	CcSEcCtD
Temazepam—Constipation—Mitoxantrone—lymphatic system cancer	0.00199	0.00294	CcSEcCtD
Temazepam—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00196	0.00289	CcSEcCtD
Temazepam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00192	0.00284	CcSEcCtD
Temazepam—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00188	0.00278	CcSEcCtD
Temazepam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00185	0.00273	CcSEcCtD
Temazepam—Vomiting—Bleomycin—lymphatic system cancer	0.00182	0.0027	CcSEcCtD
Temazepam—Drowsiness—Methotrexate—lymphatic system cancer	0.00182	0.00269	CcSEcCtD
Temazepam—Depression—Methotrexate—lymphatic system cancer	0.00181	0.00268	CcSEcCtD
Temazepam—Asthenia—Carmustine—lymphatic system cancer	0.0018	0.00266	CcSEcCtD
Temazepam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00176	0.0026	CcSEcCtD
Temazepam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00172	0.00254	CcSEcCtD
Temazepam—Asthenia—Vincristine—lymphatic system cancer	0.00172	0.00254	CcSEcCtD
Temazepam—Diarrhoea—Carmustine—lymphatic system cancer	0.00171	0.00253	CcSEcCtD
Temazepam—Nausea—Bleomycin—lymphatic system cancer	0.0017	0.00252	CcSEcCtD
Temazepam—Agranulocytosis—Methotrexate—lymphatic system cancer	0.0017	0.00251	CcSEcCtD
Temazepam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00167	0.00247	CcSEcCtD
Temazepam—Dizziness—Carmustine—lymphatic system cancer	0.00166	0.00245	CcSEcCtD
Temazepam—Diarrhoea—Vincristine—lymphatic system cancer	0.00164	0.00242	CcSEcCtD
Temazepam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00159	0.00235	CcSEcCtD
Temazepam—Vomiting—Carmustine—lymphatic system cancer	0.00159	0.00235	CcSEcCtD
Temazepam—Dizziness—Vincristine—lymphatic system cancer	0.00158	0.00234	CcSEcCtD
Temazepam—Visual impairment—Methotrexate—lymphatic system cancer	0.00157	0.00233	CcSEcCtD
Temazepam—Headache—Carmustine—lymphatic system cancer	0.00157	0.00232	CcSEcCtD
Temazepam—Vomiting—Vincristine—lymphatic system cancer	0.00152	0.00225	CcSEcCtD
Temazepam—Headache—Vincristine—lymphatic system cancer	0.0015	0.00221	CcSEcCtD
Temazepam—Nausea—Carmustine—lymphatic system cancer	0.00149	0.0022	CcSEcCtD
Temazepam—Vomiting—Mitoxantrone—lymphatic system cancer	0.00148	0.00219	CcSEcCtD
Temazepam—Headache—Mitoxantrone—lymphatic system cancer	0.00146	0.00216	CcSEcCtD
Temazepam—Alopecia—Methotrexate—lymphatic system cancer	0.00144	0.00213	CcSEcCtD
Temazepam—Nausea—Vincristine—lymphatic system cancer	0.00142	0.0021	CcSEcCtD
Temazepam—Nausea—Mitoxantrone—lymphatic system cancer	0.00138	0.00204	CcSEcCtD
Temazepam—Back pain—Methotrexate—lymphatic system cancer	0.00138	0.00203	CcSEcCtD
Temazepam—Vision blurred—Methotrexate—lymphatic system cancer	0.00134	0.00198	CcSEcCtD
Temazepam—Vertigo—Methotrexate—lymphatic system cancer	0.00128	0.00189	CcSEcCtD
Temazepam—Convulsion—Methotrexate—lymphatic system cancer	0.00123	0.00182	CcSEcCtD
Temazepam—Confusional state—Methotrexate—lymphatic system cancer	0.00117	0.00173	CcSEcCtD
Temazepam—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00114	0.00168	CcSEcCtD
Temazepam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00112	0.00166	CcSEcCtD
Temazepam—Anorexia—Methotrexate—lymphatic system cancer	0.00111	0.00163	CcSEcCtD
Temazepam—Hypotension—Methotrexate—lymphatic system cancer	0.00108	0.0016	CcSEcCtD
Temazepam—Dyspnoea—Methotrexate—lymphatic system cancer	0.00103	0.00153	CcSEcCtD
Temazepam—Somnolence—Methotrexate—lymphatic system cancer	0.00103	0.00152	CcSEcCtD
Temazepam—Decreased appetite—Methotrexate—lymphatic system cancer	0.00101	0.00149	CcSEcCtD
Temazepam—Fatigue—Methotrexate—lymphatic system cancer	0.001	0.00148	CcSEcCtD
Temazepam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000956	0.00141	CcSEcCtD
Temazepam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000855	0.00126	CcSEcCtD
Temazepam—Asthenia—Methotrexate—lymphatic system cancer	0.000832	0.00123	CcSEcCtD
Temazepam—Pruritus—Methotrexate—lymphatic system cancer	0.000821	0.00121	CcSEcCtD
Temazepam—Diarrhoea—Methotrexate—lymphatic system cancer	0.000794	0.00117	CcSEcCtD
Temazepam—Dizziness—Methotrexate—lymphatic system cancer	0.000767	0.00113	CcSEcCtD
Temazepam—Vomiting—Methotrexate—lymphatic system cancer	0.000738	0.00109	CcSEcCtD
Temazepam—Headache—Methotrexate—lymphatic system cancer	0.000727	0.00107	CcSEcCtD
Temazepam—Nausea—Methotrexate—lymphatic system cancer	0.000689	0.00102	CcSEcCtD
